| Name | Title | Contact Details |
|---|---|---|
Julie Daoust |
Head of US R&D and Open Innovation | Profile |
Stephen Valentin |
Director, Global People Operations and Technology | Profile |
Andrea Trincanello |
Head of Global People Operations and Total Rewards | Profile |
Anna Lindskog |
Global Chief of Staff and Sustainability | Profile |
Sigrid Schelstraete |
Head of Human Resource | Profile |
Holloway consists of privately held, affiliated companies in the agricultural, environmental, mining, and logistics industries. Holloway strives for excellence in product, quality and customer service.
FanFood is a mobile ordering platform dedicated to enhancing the guest experience at live events. The consumer app allows fans to explore concessions, order-ahead for express pick-up, or get them delivered to their seat. The company helps take stadiums goes cashless and designed to take pressure off concession lines, improve staff efficiency and increase sales. FanFood has secured partnerships with properties owned and operated by the MLS, NCAA, MiLB Baseball, and Formula One. FanFood is a nationwide brand built for sports and live entertainment. FanFood is executing events every day and has over 25,000 users on the platform.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.
Welcome fearless traveler. Herein there be great riches. Park your preconceptions.